kabutan

TOCALO Co.,Ltd.(3433) Summary

3433
TSE Prime
TOCALO Co.,Ltd.
2,181
JPY
-2
(-0.09%)
Dec 5, 12:45 pm JST
14.06
USD
Dec 4, 10:45 pm EST
Result
PTS
outside of trading hours
2,179
Dec 5, 12:35 pm JST
Summary Chart Historical News Financial Result
PER
15.5
PBR
2.07
Yield
3.21%
Margin Trading Ratio
3.70
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
2,165 JPY 13.95 USD
Previous Close Dec 4
2,183 JPY 14.05 USD
High Dec 5, 9:34 am
2,193 JPY 14.13 USD
Low Dec 5, 9:00 am
2,160 JPY 13.92 USD
Volume
57,600
Trading Value
0.13B JPY 0.81M USD
VWAP
2178.39 JPY 14.04 USD
Minimum Trading Value
218,100 JPY 1,406 USD
Market Cap
0.13T JPY 0.86B USD
Number of Trades
304
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly High
1-Year Average
587
1-Year High Nov 7, 2025
3,586
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 55,600 156,400 2.81
Nov 21, 2025 54,600 164,300 3.01
Nov 14, 2025 54,700 225,900 4.13
Nov 7, 2025 57,700 238,900 4.14
Oct 31, 2025 54,900 150,300 2.74
Company Profile
TOCALO Co., Ltd. specializes in surface treatment processing, primarily for semiconductor and LCD manufacturing equipment components. The company is a leading provider of thermal spray coating services.
Sector
Metal Products
TOCALO Co., Ltd. possesses surface modification processing technologies centered on thermal spray coating. The company applies coatings of metals, ceramics, and other materials to the surfaces of various components, including semiconductor and FPD manufacturing equipment parts, industrial machinery components such as gas turbines for power generation, and facility parts like steel rolls and chemical plant components. These coatings impart various functions such as wear resistance, heat resistance, conductivity, and electrical insulation. With domestic and international subsidiaries, TOCALO also engages in PVD treatment processing and maintenance services for semiconductor manufacturing equipment parts. The company's technological portfolio includes TD treatment processing, ZAC coating, and PTA treatment.